Document is current
Any future updates will be listed below
-
Authors
Witte, Hanno
Künstner, Axel
Hahn, Thomas
Bernard, Veronica
Stölting, Stephanie
Kusch, Kathrin
Nagarathinam, Kumar
Khandanpour, Cyrus
von Bubnoff, Nikolas
Bauer, Arthur
Grunert, Michael
Hartung, Svenja
Arndt, Annette
Steinestel, Konrad
Merz, Hartmut
Busch, Hauke
Feller, Alfred C.
Gebauer, Niklas
-
Funding
Funding for this research was provided by:
Brigitte und Dr. Konstanze Wegener Foundation
Bundeswehrkrankenhaus Ulm
- License Information
-
More Information
Article History
Received: 5 April 2024
Accepted: 17 February 2025
First Online: 24 February 2025
Declarations
:
: This retrospective study was approved by the ethics committee of the University of Lübeck (reference-no 18–334) and conducted in accordance with the declaration of Helsinki. Patients at the Reference center for Hematopathology have provided written informed consent regarding routine diagnostic and academic assessment, including genomic studies of their biopsy specimen alongside transfer of their clinical data.
: NG received travel support from Janssen, BeiGene, and Roche; and serves as an advisor to Roche, AstraZeneca, Takeda, Johnson & Johnson, Incyte and Stemline. KS received honoraria and serves as an advisor to AstraZeneca, BMS, MSD, Sanofi and Boehringer Ingelheim. HW received honoraria from BeiGene, BMS, Johnson & Johnson and Viatris as well as travel support from Johnson & Johnson.
